Additional Proxy Soliciting Materials (definitive) (defa14a)
June 02 2014 - 9:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June
2, 2014
American Realty Capital Healthcare Trust,
Inc.
(Exact Name of Registrant as Specified in
Charter)
Maryland
|
|
000-54688
|
|
27-3306391
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
405 Park Avenue
New York, New York 10022
|
(Address, including zip code, of Principal
Executive Offices)
Registrant's telephone number, including
area code: (212) 415-6500
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
x
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
As previously disclosed, American Realty
Capital Healthcare Trust, Inc. (the “Company”) and Ventas, Inc. (“Ventas”) entered into a definitive agreement
(“Merger Agreement”), dated as of June 1, 2014, pursuant to which, among other things and subject to the satisfaction
or waiver of specified conditions, the Company will merge with and into a wholly-owned subsidiary of Ventas (the “Merger”).
The Company prepared an investor presentation with respect to the contemplated Merger. Directors, officers and other representatives
of the Company and Ventas will present some or all of such investor presentation to various conferences and meetings in the coming
months. A copy of the investor presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Such investor presentation
shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “
Exchange Act
”), or otherwise be subject to the liabilities of that Section. The information
in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act
of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing.
Item 8.01. Other Events.
A copy of the investor presentation is furnished as Exhibit
99.1 to this Current Report on Form 8-K.
Additional Information about the Proposed Merger and Where
to Find It
This communication does not constitute an
offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with
the proposed Merger, the Company expects to prepare and file with the SEC a proxy statement and Ventas expects to prepare and file
with the SEC a registration statement on Form S-4 containing the Company’s proxy statement (the “
proxy statement/prospectus
”),
as well as other documents, with respect to Ventas’ proposed acquisition of the Company.
INVESTORS ARE URGED TO READ THE
PROXY STATEMENT/PROSPECTUS (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER RELEVANT DOCUMENTS FILED BY THE COMPANY
OR VENTAS WITH THE SEC IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER.
Investors may obtain free copies of the
registration statement, proxy statement/prospectus and other relevant documents filed by the Company and Ventas, as applicable,
with the SEC (if and when they become available) through the website maintained by the SEC at www.sec.gov. Copies of the documents
filed by the Company with the SEC are also available free of charge on the Company’s website at http://www.archealthcaretrust.com,
and copies of the documents filed by Ventas with the SEC are available free of charge on Ventas’ website at http://www.ventasreit.com.
The Company, American Realty Capital Healthcare
Advisor, LLC (the “Advisor”), Ventas and their respective directors and executive officers may be deemed to be participants
in the solicitation of proxies from the Company’s stockholders in respect of the proposed Merger. Information regarding these
persons can be found, with respect to the Company and the Advisor, in the Company’s definitive proxy statement filed with
the SEC on April 28, 2014 and, with respect to Ventas, in Ventas’ definitive proxy statement for Ventas’ 2014 annual
meeting of stockholders, filed with the SEC on April 4, 2014. Additional information regarding the interests of such potential
participants will be included in the proxy statement/prospectus and other relevant documents filed by the Company and Ventas with
the SEC in connection with the proposed Merger if and when they become available. These documents are available free of charge
on the SEC’s website and from the Company or Ventas, as applicable, using the sources indicated above.
Forward-Looking Statements
Information set forth in this Current Report
on Form 8-K (including information included or incorporated by reference herein) contains “forward-looking statements”
(as defined in Section 21E of the Exchange Act), which reflect the Company’s and Ventas’ expectations regarding future
events. The forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results
to differ materially from those contained in the forward-looking statements. Such forward-looking statements include, but are not
limited to whether and when the transactions contemplated by the Merger Agreement will be consummated, the new combined company’s
plans, market and other expectations, objectives, intentions and other statements that are not historical facts.
The following additional factors, among
others, could cause actual results to differ from those set forth in the forward-looking statements: the ability to obtain regulatory
approvals for the transaction and the approval of the Merger Agreement by the stockholders of the Company; unexpected costs or
unexpected liabilities that may arise from the transaction, whether or not consummated; the inability to retain key personnel;
future regulatory or legislative actions that could adversely affect either company or the healthcare industry generally; and the
overall state of the healthcare industry. Additional factors that may affect future results are contained in the Company’s
and Ventas’ filings with the SEC, which are available at the SEC’s website at www.sec.gov. The Company and Ventas disclaim
any obligation to update and revise statements contained in these materials based on new information or otherwise.
Item 9.01 Financial Statements and Exhibits.
Exhibit No
|
|
Description
|
|
|
|
99.1
|
|
Investor presentation.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
AMERICAN REALTY CAPITAL HEALTHCARE TRUST, INC.
|
|
|
|
Date: June 2, 2014
|
By:
|
/s/ Thomas P. D’Arcy
|
|
|
Name: Thomas P. D’Arcy
|
|
|
Title: Chief Executive Officer
|
(MM) (NASDAQ:HCT)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:HCT)
Historical Stock Chart
From Jul 2023 to Jul 2024